{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T12:42:44Z","timestamp":1768999364193,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Invasive mold disease (IMD) of the central nervous system (CNS) is a severe infectious complication in immunocompromised patients, but early microbiological diagnosis is difficult. As data on the value of biomarkers in the CNS are scarce, in particular in children, we retrospectively analyzed the performance of galactomannan (GM) and PCR assays in CNS samples of 15 children with proven and probable CNS IMD and of 32 immunocompromised children without fungal infection. Galactomannan in the cerebrospinal fluid (CSF) was assessed in nine of the 15 pediatric patients and was positive in five of them. Polymerase chain reaction (PCR) was performed in eight of the 15 patients and detected nucleic acids from molds in six patients. Galactomannan and PCR in CNS samples were the only positive microbiologic parameter in the CNS in three and two patients, respectively. In four patients, PCR specified the pathogen detected in microscopy. Galactomannan and PCR results remained negative in the CSF of all immunocompromised children without evidence for CNS IMD. Our data suggest that GM and PCR in CNS specimens are valuable additional tools in diagnosing CNS IMD and should be included in the work up of all pediatric patients with suspected mold disease of the CNS.<\/jats:p>","DOI":"10.1038\/s41598-019-49426-0","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T10:04:12Z","timestamp":1568109852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children"],"prefix":"10.1038","volume":"9","author":[{"given":"Thomas","family":"Lehrnbecher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Michael","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Cario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8134-7350","authenticated-orcid":false,"given":"Michaela","family":"D\u00f6ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Moser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Urs","family":"M\u00fccke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Poyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Rieken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Temme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1544-9903","authenticated-orcid":false,"given":"Sebastian","family":"Voigt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melchior","family":"Lauten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"49426_CR1","doi-asserted-by":"publisher","first-page":"E53","DOI":"10.3314\/mmj.18-00003","volume":"59","author":"Y Suzuki","year":"2018","unstructured":"Suzuki, Y., Togano, T., Ohto, H. & Kume, H. Visceral Mycoses in Autopsied Cases in Japan from 1989 to 2013. Med Mycol J 59, E53\u2013E62 (2018).","journal-title":"Med Mycol J"},{"key":"49426_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S1474-4422(18)30030-9","volume":"17","author":"S Schwartz","year":"2018","unstructured":"Schwartz, S., Kontoyiannis, D. P., Harrison, T. & Ruhnke, M. Advances in the diagnosis and treatment of fungal infections of the CNS. Lancet Neurol 17, 362\u2013372 (2018).","journal-title":"Lancet Neurol"},{"key":"49426_CR3","unstructured":"Cornely, O. A. et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium Lancet Infect Dis (in press)."},{"key":"49426_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12281-014-0213-y","volume":"9","author":"A Hassler","year":"2015","unstructured":"Hassler, A., Porto, L. & Lehrnbecher, T. Cerebral Fungal Infection in Pediatric Cancer Patients. Current Fungal Infection Reports 9, 6\u201314 (2015).","journal-title":"Current Fungal Infection Reports"},{"key":"49426_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/978-1-4939-6515-1_3","volume":"1508","author":"T Lehrnbecher","year":"2017","unstructured":"Lehrnbecher, T., Becker, K. & Groll, A. H. Current Algorithms in Fungal Diagnosis in the Immunocompromised Host. Methods Mol Biol 1508, 67\u201384 (2017).","journal-title":"Methods Mol Biol"},{"key":"49426_CR6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/myc.12838","volume":"61","author":"M Ruhnke","year":"2018","unstructured":"Ruhnke, M. et al. Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO). Mycoses 61, 796\u2013813 (2018).","journal-title":"Mycoses"},{"key":"49426_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/bmt.2011.178","volume":"47","author":"O Marchetti","year":"2012","unstructured":"Marchetti, O. et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 47, 846\u2013854 (2012).","journal-title":"Bone Marrow Transplant"},{"key":"49426_CR8","doi-asserted-by":"publisher","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","volume":"15","author":"AH Groll","year":"2014","unstructured":"Groll, A. H. et al. Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation. Lancet Oncol 15, e327\u2013340 (2014).","journal-title":"Lancet Oncol"},{"key":"49426_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1093\/cid\/ciw592","volume":"63","author":"T Lehrnbecher","year":"2016","unstructured":"Lehrnbecher, T. et al. Galactomannan, beta-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis. Clin Infect Dis 63, 1340\u20131348 (2016).","journal-title":"Clin Infect Dis"},{"key":"49426_CR10","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/321887","volume":"33","author":"D Buchheidt","year":"2001","unstructured":"Buchheidt, D. et al. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin Infect Dis 33, 428\u2013435 (2001).","journal-title":"Clin Infect Dis"},{"key":"49426_CR11","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/jac\/dks208","volume":"67","author":"M Reinwald","year":"2012","unstructured":"Reinwald, M. et al. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother 67, 2260\u20132267 (2012).","journal-title":"J Antimicrob Chemother"},{"key":"49426_CR12","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/ppul.22670","volume":"48","author":"M de Mol","year":"2013","unstructured":"de Mol, M. et al. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatr Pulmonol 48, 789\u2013796 (2013).","journal-title":"Pediatr Pulmonol"},{"key":"49426_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/myc.12443","volume":"59","author":"D Buchheidt","year":"2016","unstructured":"Buchheidt, D. et al. Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients\u2013is Aspergillus PCR appropriate? Mycoses 59, 67\u201374 (2016).","journal-title":"Mycoses"},{"key":"49426_CR14","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/JCM.02913-15","volume":"54","author":"GM Chong","year":"2016","unstructured":"Chong, G. M. et al. Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid. J Clin Microbiol 54, 428\u2013431 (2016).","journal-title":"J Clin Microbiol"},{"key":"49426_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijid.2007.01.013","volume":"11","author":"J Dotis","year":"2007","unstructured":"Dotis, J., Iosifidis, E. & Roilides, E. Central nervous system aspergillosis in children: a systematic review of reported cases. Int J Infect Dis 11, 381\u2013393 (2007).","journal-title":"Int J Infect Dis"},{"key":"49426_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1128\/JCM.40.4.1496-1499.2002","volume":"40","author":"C Viscoli","year":"2002","unstructured":"Viscoli, C. et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 40, 1496\u20131499 (2002).","journal-title":"J Clin Microbiol"},{"key":"49426_CR17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1007\/s00467-003-1113-5","volume":"18","author":"E Roilides","year":"2003","unstructured":"Roilides, E. et al. Cerebral aspergillosis in an infant with corticosteroid-resistant nephrotic syndrome. Pediatr Nephrol 18, 450\u2013453 (2003).","journal-title":"Pediatr Nephrol"},{"key":"49426_CR18","doi-asserted-by":"publisher","first-page":"e8893","DOI":"10.1097\/MD.0000000000008893","volume":"96","author":"Y Wang","year":"2017","unstructured":"Wang, Y., Li, D., Qiao, L. & Zhao, F. Infant Central Nervous System Aspergillosis with First-episode of Intracranial Hemorrhage: A case report. Medicine (Baltimore) 96, e8893 (2017).","journal-title":"Medicine (Baltimore)"},{"key":"49426_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/jpids\/piv014","volume":"5","author":"CM Salvatore","year":"2016","unstructured":"Salvatore, C. M. et al. (1\u2013>3)-beta-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients. J Pediatric Infect Dis Soc 5, 277\u2013286 (2016).","journal-title":"J Pediatric Infect Dis Soc"},{"key":"49426_CR20","doi-asserted-by":"publisher","first-page":"e56706","DOI":"10.1371\/journal.pone.0056706","volume":"8","author":"M Reinwald","year":"2013","unstructured":"Reinwald, M. et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One 8, e56706 (2013).","journal-title":"PLoS One"},{"issue":"889","key":"49426_CR21","first-page":"e881","volume":"23","author":"S Imbert","year":"2017","unstructured":"Imbert, S. et al. Performance of Aspergillus PCR in cerebrospinal fluid for the diagnosis of cerebral aspergillosis. Clin Microbiol Infect 23(889), e881\u2013889 (2017).","journal-title":"Clin Microbiol Infect"},{"key":"49426_CR22","doi-asserted-by":"publisher","first-page":"71","DOI":"10.7182\/pit2013386","volume":"23","author":"G Soeffker","year":"2013","unstructured":"Soeffker, G. et al. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Prog Transplant 23, 71\u201374 (2013).","journal-title":"Prog Transplant"},{"key":"49426_CR23","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1128\/JCM.00905-15","volume":"53","author":"PL White","year":"2015","unstructured":"White, P. L. et al. Clinical Performance of Aspergillus PCR for Testing Serum and Plasma: a Study by the European Aspergillus PCR Initiative. J Clin Microbiol 53, 2832\u20132837 (2015).","journal-title":"J Clin Microbiol"},{"key":"49426_CR24","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1128\/JCM.00747-15","volume":"53","author":"A Koltze","year":"2015","unstructured":"Koltze, A. et al. Beta-D-Glucan Screening for the Detection of Invasive Fungal Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. J Clin Microbiol 53, 2605\u20132610 (2015).","journal-title":"J Clin Microbiol"},{"key":"49426_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1111\/myc.12664","volume":"60","author":"C Calitri","year":"2017","unstructured":"Calitri, C. et al. Performance of 1,3-beta-D-glucan for diagnosing invasive fungal diseases in children. Mycoses 60, 789\u2013795 (2017).","journal-title":"Mycoses"},{"key":"49426_CR26","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2016.07.007","volume":"73","author":"J Guitard","year":"2016","unstructured":"Guitard, J. et al. Detection of beta-D-glucan for the diagnosis of invasive fungal infection in children with hematological malignancy. J Infect 73, 607\u2013615 (2016).","journal-title":"J Infect"},{"key":"49426_CR27","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/mmy\/myw118","volume":"55","author":"TK Chen","year":"2017","unstructured":"Chen, T. K. et al. Successful treatment of Aspergillus ventriculitis through voriconazole adaptive pharmacotherapy, immunomodulation, and therapeutic monitoring of cerebrospinal fluid (1\u2013>3)-beta-D-glucan. Med Mycol 55, 109\u2013117 (2017).","journal-title":"Med Mycol"},{"key":"49426_CR28","doi-asserted-by":"publisher","first-page":"e27806","DOI":"10.1002\/pbc.27806","volume":"66","author":"M Lauten","year":"2019","unstructured":"Lauten, M. et al. Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients. Pediatr Blood Cancer 66, e27806 (2019).","journal-title":"Pediatr Blood Cancer"},{"issue":"Suppl 2","key":"49426_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/j.1439-0507.2012.02178.x","volume":"55","author":"S Schwartz","year":"2012","unstructured":"Schwartz, S. [Diagnostic imaging methods and therapy options for cerebral aspergillosis]. Mycoses 55(Suppl 2), 10\u201316 (2012).","journal-title":"Mycoses"},{"key":"49426_CR30","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"B De Pauw","year":"2008","unstructured":"De Pauw, B. et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group. Clin Infect Dis 46, 1813\u20131821 (2008).","journal-title":"Clin Infect Dis"},{"key":"49426_CR31","doi-asserted-by":"publisher","first-page":"12970","DOI":"10.3390\/ijms140712970","volume":"14","author":"GL Johnson","year":"2013","unstructured":"Johnson, G. L. et al. Significant decline in Galactomannan Signal during storage of clinical serum samples. Int J Mol Sci 14, 12970\u201312977 (2013).","journal-title":"Int J Mol Sci"},{"key":"49426_CR32","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fmicb.2018.00740","volume":"9","author":"PM Rath","year":"2018","unstructured":"Rath, P. M. & Steinmann, J. Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples. Front Microbiol 9, 740 (2018).","journal-title":"Front Microbiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49426-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:25:23Z","timestamp":1671283523000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49426-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49426"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49426-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Lehrnbecher received personal fees from Gilead Sciences, MSD\/Merck and Astellas. In addition, he was given a research grant by Gilead Sciences. Prof. Groll received personal fees from Gilead Sciences, MSD\/Merck, Sharp & Dohme, Pfizer and Amplyx. In addition, he was given a research grant by Gilead Sciences. Prof. Lauten received personal fees from MSD\/Merck. All other authors have indicated they have no financial relationships relevant to this article to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12950"}}